Novel Treatment for Spinal Cord Injury Identified

Novel enzyme treatment that may reduce inflammation and scarring that prevent neuronal regeneration has been identified by a research team that identified the neuroprotective effect of blood glutamate scavengers in spinal cord injury.

A novel enzyme that can be given through intravenous injection for the treatment of spinal cord injury has been identified by a research team at the American Friends of Tel Aviv University.

The enzyme, when given just hours after an accident has the potential to inflammation and scarring that leads to neural death.

Spinal Cord Injury - Causes, Symptoms, Diagnosis, Treatment & Prevention
Spinal cord injury is an injury to the spinal cord that results in temporary or permanent changes in its function.

‘A new therapy for spinal cord injury that is based on an enzyme that diminishes a cascade of pathological events responsible for neuronal death, such as inflammation and scarring, has been identified.’

"Primary mechanical damage to spinal cord tissue kills a certain amount of neuronal cells. But there's secondary damage due to the release of excess glutamates, which are responsible for additional functional disability," Dr. Goldshmit says. "The main idea is to reduce the secondary damage as soon as possible, to block the body's natural reaction to spinal cord trauma. This is the role of the enzyme injection we devised."

"When this new treatment will be available to paramedics, the consequences of injuries could be dramatically reduced," Dr. Ruban says.

"Don't wait to diagnose"
Dr. Ruban worked with the late Prof. Vivian I. Teichberg of the Weizmann Institute of Science to develop the "blood glutamate scavenging approach," a treatment based on controlling the levels of glutamate, the most abundant free amino acid in the central nervous system. Glutamate accounts for approximately 60 percent of total neurotransmitter activity in the brain. Dr. Ruban's research has shown the positive effect of the blood glutamate treatment in models of glioblastoma, ALS and others.

Autonomic Dysreflexia - Causes, Symptoms, Diagnosis, Treatment, Prevention
Autonomic dysreflexia is a condition that occurs in patients with spinal cord injuries especially in the T5 and T6 levels. This condition is characterized by hyper activity of the autonomic nervous system.

"Our takeaway is, 'Don't wait to diagnose it, treat it,'" Dr. Ruban says. "It's similar to aspirin, which can rescue a cardiac patient from irreversible damage if taken within the first few hours of a heart attack. We suggest administering the injection even in cases of uncertain diagnosis. There's no side effect to the injection, but it might just mitigate secondary damage and dramatically improve the quality of a person's life."

According to the research, neurotrauma produces the immediate elevation of extracellular glutamate levels, which leads to inflammation, scar formation and, consequentially, neuronal death.

Spinal Injury - Symptom Evaluation
Spinal Injury refers to damage to spinal cord that runs below the brain through the back. Injury to spinal cord is a severe injury as the damage is irreversible and it can be life-threatening.

"Our new treatment aims to lower levels of glutamate, which is released in toxic quantities after trauma, by intravenous administration of blood glutamate scavengers (BGS), such as recombinant enzyme glutamate-oxaloacetate transaminase (rGOT1) and its co-substrate," Dr. Ruban says.

"If we manage to reduce the amount of glutamate that is released initially, we can moderate the inflammation and scarring, thereby moderating the damage to the tissue and enabling neuronal cells to survive," Dr. Goldshmit adds.

Hemiplegia - Causes, Symptoms, Diagnosis, Treatment and Prevention
Hemiplegia is a condition that is characterized by paralysis of one half of the body, usually due to a brain lesion on the opposite side. It may be congenital (cerebral palsy) or acquired later in life due to illness.

Initial success in mouse models
The research team studied the neuroprotective effect of the blood glutamate scavengers in mouse models of spinal cord injury. After receiving the treatment for five consecutive days, the mice significantly recovered from the injury.

"The treatment increased the survival of neurons at the lesion site and enabled axonal regeneration into the injury site, which resulted in significant functional recovery compared with the untreated mice," Dr. Ruban concludes. "This indicates that drug intervention with blood glutamate scavengers following spinal cord injury may be neuroprotective and may create a regenerative environment."

Source-Eurekalert